Suppression of Coronary Atherosclerosis by Helix B Surface Peptide, a Nonerythropoietic, Tissue-Protective Compound Derived from Erythropoietin

Abstract Erythropoietin (EPO), a type I cytokine originally identified for its critical role in hematopoiesis, has been shown to have non-hematopoietic, tissue-protective effects, including suppression of atherosclerosis. However, prothrombotic effects of EPO hinder its potential clinical use in non...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Hiroto Ueba, Masashi Shiomi, Michael Brines, Michael Yamin, Tsutomu Kobayashi, Junya Ako, Shin-ichi Momomura, Anthony Cerami, Masanobu Kawakami
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2013-05-01
Colecção:	Molecular Medicine
Assuntos:	Helix B Surface Peptide Coronary Atherosclerotic Lesions Human Umbilical Vein Endothelial Cells (HUVECs) Antiatherosclerotic Effects Spontaneous Myocardial Infarction
Acesso em linha:	https://doi.org/10.2119/molmed.2013.00037
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!